Condensed Consolidated Balance Sheets (USD $)	Dec. 31, 2011	Sep. 30, 2011
ASSETS
Cash and cash equivalents	$ 160,465	$ 147,907
Prepaid expenses	58,910	59,264
Total current assets	219,375	207,171
Other assets:
Available-for-sale investments	18,560	8,320
IT Property, net	13,750	0
Intellectual property, net	133,674	126,917
Total other assets	165,984	135,237
Total assets	385,359	342,408
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	337,800	341,835
Accounts payable - related parties	35,649	28,732
Deferred sales	4,966	0
Convertible notes payable, net	343,689	606,976
Accrued expenses	122,367	21,684
Total current liabilities	844,471	999,227
Commitments and contingencies	0	0
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued and outstanding; $100 per share liquidation preference	0	0
Common stock, $.001 par value; authorized 400,000,000 shares; 110,912,035 and 93,612,039 shares issued and outstanding at December 31, 2011 and September 30, 2010, respectively	110,912	93,612
Additional paid-in capital	18,413,972	12,667,350
Stock options	(4,878,708)	(680,711)
Non-controlling interest	(126,344)	(126,344)
Deferred consulting fees	(920,637)	(541,558)
Accumulated other comprehensive income	12,830	2,590
Accumulated deficit:
During the development stage	(3,194,284)	(2,194,904)
Other	(9,876,853)	(9,876,854)
Total accumulated deficit	(13,071,137)	(12,071,758)
Total stockholders' deficit	(459,112)	(656,819)
Total liabilities and stockholders' deficit	$ 385,359	$ 342,408